Search Results1-17 of  17

  • 小比賀 聡 ID: 9000018886558

    Articles in CiNii:1

    • Development of Chemically Modified Nucleic-Acid Aptamers Towards the Application to Medicine and Diagnostic Agents (2012)
  • 小比賀 聡 ID: 9000018896526

    Articles in CiNii:1

    • 糖部架橋型核酸の医薬への応用 (特集 創薬シーズとして期待される核酸医薬品 : その展望と課題) (2012)
  • 小比賀 聡 ID: 9000241815329

    Articles in CiNii:1

    • Novel therapy for hyoer LDL-cholesterolemia using anti-PCSK9 antibody (2013)
  • 小比賀 聡 ID: 9000259294870

    Articles in CiNii:1

    • Creation of DNA-based 2', 4'-bridged/locked nucleic acid aptamers (2014)
  • 小比賀 聡 ID: 9000341530122

    Articles in CiNii:1

    • 核酸医薬開発における化学 (特集 日本発次世代創薬のための化学) (2017)
  • 小比賀 聡 ID: 9000363277066

    Articles in CiNii:4

    • Comprehensive Strategy for Retinal Neuroprotection : Challenging the Clinical Application (2012)
    • Sugar and Base Modifications Used in Oligonucleotide Therapeutics (2018)
    • UCSB留学体験記 (2003)
  • 小比賀 聡 ID: 9000387475666

    Articles in CiNii:1

    • Preclinical Safety Evaluation for Oligonucleotide Therapeutics : Virtual Case Studies(1)Waiver of Evaluation for "On-target Toxicity" (2018)
  • 小比賀 聡 ID: 9000388487160

    Articles in CiNii:1

    • Preclinical Safety Evaluation for Oligonucleotide Therapeutics : Virtual Case Studies(2)Toxicity Evaluation of Oligonucleotide Therapeutics for Local Administration (2018)
  • 小比賀 聡 ID: 9000390924425

    Articles in CiNii:1

    • Preclinical Safety Evaluation for Oligonucleotide Therapeutics : Virtual Case Studies(3)Effective Reuse of Data Acquired in the Past (2018)
  • 小比賀 聡 ID: 9000395383160

    Articles in CiNii:1

    • 鼎談 核酸医薬の現状と展望 (特集 核酸医薬の現状と展望) (2018)
  • 小比賀 聡 ID: 9000398457287

    Articles in CiNii:1

    • 進む核酸医薬品の開発 (2018)
  • 小比賀 聡 ID: 9000402486217

    Articles in CiNii:1

    • Usefulness of chemically modified nucleic acids (2019)
  • OBIKA Satoshi ID: 1000080243252

    Graduate School of Pharmaceutical Sciences, Osaka University (2009 from CiNii)

    Articles in CiNii:23

    • Stereospecific 4-Hydrogen Transfer in the Asymmetric Reduction Using(Ss)-3-(p-Tolylsulfinyl)-1, 4-dihydropyridines, NADH Model Compounds (1996)
    • Gene Transfer Mediated by YKS-220 Cationic Particles : Convenient and Efficient Gene Delivery Reagent (1999)
    • Syntheses and Properties of Novel Conformationally Restrained Nucleoside Analogues (1999)
  • OBIKA Satoshi ID: 9000254239331

    Articles in CiNii:1

    • Novel and chiral hantzsch-type 1,4-dihydropyridines having A p-tolylsulfinyl group. Synthesis and biological activities as calcium channel antagonists. (1995)
  • OBIKA Satoshi ID: 9000403275537

    Graduate School of Pharmaceutical Sciences, Osaka University (2019 from CiNii)

    Articles in CiNii:1

    • Species differences in innate immune responses by antisense oligonucleotides (2019)
  • Obika Satoshi ID: 9000021834747

    Graduate School of Pharmaceutical Sciences, Osaka University (2018 from CiNii)

    Articles in CiNii:13

    • Novel and artificial RNAs (2005)
    • TRANSDERMAL PENETRATION-ENHANCING EFFECT AND ITS MECHANISM OF NOVEL TRIGLYCERIDES HAVING QUATERNARY AMMONIUM GROUP (1994)
    • Synthesis and Properties of 2',4'-Bridged Nucleic Acids Containing Multiple Heteroatoms in the Bridges (2016)
  • Obika Satoshi ID: 9000404635932

    Graduate School of Pharmaceutical Sciences, Osaka University (2019 from CiNii)

    Articles in CiNii:1

    • Derivative Synthesis toward Enhancement of the Biophysical Properties of 2′,4′-Bridged Nucleic Acids (2019)
Page Top